» Articles » PMID: 23671529

Preoperative Hydronephrosis and Diabetes Mellitus Predict Poor Prognosis in Upper Urinary Tract Urothelial Carcinoma

Overview
Specialty Urology
Date 2013 May 15
PMID 23671529
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: We assess the impact of traditional prognostic factors, tumour location, degree of hydronephrosis and diabetes mellitus (DM) on the survival of patients treated for upper urinary tract urothelial carcinoma (UUTUC).

Methods: From January 2004 to March 2010, we analyzed data from 114 patients with UUTUC who underwent nephroureterectomy with a bladder cuff excision. Median patient age was 71 years and median follow-up was 26.5 months. The influence of traditional prognostic factors, including DM, tumour stage, grade, location and degree of hydronephrosis, on recurrence-free survival (RFS) rates were analyzed using Kaplan-Meier analysis and Cox proportional hazards regression model.

Results: Among 61 renal pelvis and 53 ureteral tumour cases, recurrence was identified in 71 cases (62.3%). Kaplan-Meier analysis showed that degree of hydronephrosis was associated with RFS (p = 0.001). DM and degree of hydronephrosis were independent factors for RFS in Cox proportional regression analysis (HR=1.8 CI: 1.01-3.55, p = 0.04), (HR=3.7, CI: 2.0-6.5, p = 0.001). All patients with ureteral tumour had no worse prognosis than those with renal pelvis tumour, but the pT2 patients with ureteral tumour had a worse prognosis than those with renal pelvis tumour with a median RFS of 9 months (range: 2.6-15.3 months) and 29 months (range: 8.0-13.2 months), respectively (p = 0.028).

Conclusions: Tumour location is not a factor influencing RFS, except in the pT2 stage. However, severe hydronephrosis is associated with a higher recurrence in UUTUC. Also, DM is related to disease recurrence. Further prospective studies are needed to establish the prognostic significance of DM in large populations.

Citing Articles

Outcomes of laparoscopic, robotic and open nephroureterectomy with bladder cuff excision in patients with T3T4 upper urinary tract urothelial carcinoma: a multi-center retrospective study.

Fang J, Yeh H, Lee H, Weng H, Tai T, Huang C BMC Urol. 2024; 24(1):231.

PMID: 39434129 PMC: 11492713. DOI: 10.1186/s12894-024-01622-5.


The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study.

Yeh H, Chang C, Fang J, Chen I, Lin J, Hong J Front Oncol. 2022; 12:872849.

PMID: 35719933 PMC: 9201473. DOI: 10.3389/fonc.2022.872849.


Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.

Kim S, Song M, Joung J, Chung J, Lee K, Seo H Investig Clin Urol. 2019; 60(6):432-442.

PMID: 31692890 PMC: 6821986. DOI: 10.4111/icu.2019.60.6.432.


Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray.

Kim S, Park W, Park B, Chung J, Joung J, Lee K Cancer Res Treat. 2019; 52(1):128-138.

PMID: 31291718 PMC: 6962485. DOI: 10.4143/crt.2019.119.


Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.

Itami Y, Miyake M, Tatsumi Y, Gotoh D, Hori S, Morizawa Y Int J Clin Oncol. 2019; 24(5):533-545.

PMID: 30604161 DOI: 10.1007/s10147-018-01381-y.


References
1.
Singh A, Mo W, Dunea G, Arruda J . Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol. 1998; 9(5):802-10. DOI: 10.1681/ASN.V95802. View

2.
Tripathi A, Folsom A, Anderson K . Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer. 2002; 95(11):2316-23. DOI: 10.1002/cncr.10975. View

3.
Catto J, Yates D, Rehman I, Azzouzi A, Patterson J, Sibony M . Behavior of urothelial carcinoma with respect to anatomical location. J Urol. 2007; 177(5):1715-20. DOI: 10.1016/j.juro.2007.01.030. View

4.
Chung H, Chen K, Lin A, Chang Y, Wu H, Hsu T . Is renal function at the tumor side a prognostic factor in ureteral transitional cell carcinoma?. Urol Int. 1997; 59(3):166-9. DOI: 10.1159/000283054. View

5.
Ozsahin M, Zouhair A, Villa S, Storme G, Chauvet B, Taussky D . Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer. 1999; 35(5):738-43. DOI: 10.1016/s0959-8049(99)00012-x. View